Financials data is unavailable for this security.
Inc stmt in GBPIncome statement in GBP
Year on year
GlaxoSmithKline PLC had net income fall -89.17% from 8.42bn to 912.00m despite a 16.58% increase in revenues from 23.92bn to 27.89bn.
|Net profit margin||6.66%|
|Return on assets||3.40%|
|Return on equity||74.13%|
|Return on investment||5.27%|
Cash flow in GBP
In 2016, cash reserves at
GlaxoSmithKline PLC fell by 881.00m. However, the company earned 6.50bn from its operations for a Cash Flow Margin of 23.30%. In addition the company used 1.27bn on investing activities and also paid 6.39bn in financing cash flows.
|Cash flow per share||0.6371|
|Price/Cash flow per share||24.55|
|Book value per share||0.3486|
|Tangible book value per share||-4.68|
Balance sheet in GBP
|Total debt/total equity||10.70|
|Total debt/total capital||0.7663|
Growth rates in GBP
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -89.20%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
|Div yield(5 year avg)||0.05%|
|Div growth rate (5 year)||2.71%|
|Payout ratio (TTM)||232.52%|
|EPS growth(5 years)||-28.87|
|EPS (TTM) vs |
TTM 1 year ago